Add like
Add dislike
Add to saved papers

306 Worse Stereotactic Radiosurgery Outcomes for Intracranial Arteriovenous Malformations After Repeat vs Initial Treatment: A Matched Cohort Study.

Neurosurgery 2016 August
INTRODUCTION: Incompletely obliterated intracranial arteriovenous malformations (AVMs) after initial treatment with stereotactic radiosurgery (SRS) can be treated with a repeat session of SRS. However, the relative efficacy of repeat vs initial SRS is not well defined. The goal of this retrospective case-control study is to compare the outcomes of repeat vs initial SRS for the treatment of matched cohorts comprising angioarchitecturally similar AVMs.

METHODS: We evaluated a prospective database of AVM patients treated with SRS from 1989 to 2013. AVM patients who underwent repeat SRS with radiological follow-up of 2 years or nidus obliteration were selected for analysis and matched, in a 1:1 fashion and blinded to outcome, to previously untreated AVMs that underwent initial SRS. Statistical analyses were performed to compare the outcomes after repeat vs initial SRS.

RESULTS: The matching processes yielded 84 patients in each of the repeat and initial SRS cohorts (mean margin doses 20.7 and 20.9 Gy, respectively; P = .74). In the repeat SRS cohort, obliteration was achieved in 67%; the rates of radiologic, symptomatic, and permanent radiation-induced changes (RIC) were 35%, 10%, and 4%, respectively; and the annual post-SRS hemorrhage rate was 3.1%. Compared with the initial SRS cohort, the repeat SRS cohort had significantly lower obliteration rates (P = .038) and higher post-SRS hemorrhage rates (P = .04). The RIC rates of the 2 cohorts were not significantly different.

CONCLUSION: Repeat SRS yields considerably poorer outcomes than initial SRS for angioarchitecturally comparable AVMs. Further studies in AVM radiobiology and vascular structure are necessary to elucidate this potentially differential response.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app